(Q35134693)

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. The rhIL-1ra Phase III Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Optimizing therapeutic strategies to inhibit circulating soluble target molecules with monoclonal antibodies: example of the soluble IL-6 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Hyperresponsive febrile reactions to interleukin (IL) 1alpha and IL-1beta, and altered brain cytokine mRNA and serum cytokine levels, in IL-1beta-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Interleukin-1 receptor type I gene-deficient mice are less susceptible to Staphylococcus epidermidis biomaterial-associated infection than are wild-type mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Hematogenous bacterial meningitis in an intercellular adhesion molecule-1-deficient infant mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Serum TNF alpha in mouse typhoid and enhancement of a Salmonella infection by anti-TNF alpha antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Defective localization of the NADPH phagocyte oxidase to Salmonella-containing phagosomes in tumor necrosis factor p55 receptor-deficient macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Disruption of the genes for ClpXP protease in Salmonella enterica serovar Typhimurium results in persistent infection in mice, and development of persistence requires endogenous gamma interferon and tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Extrapulmonary tuberculosis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Restraining mycobacteria: role of granulomas in mycobacterial infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Mycobacterium bovis BCG-induced granuloma formation depends on gamma interferon and CD40 ligand but does not require CD28.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Role of trehalose dimycolate in recruitment of cells and modulation of production of cytokines and NO in tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Depressed interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Mycobacterial lipoarabinomannan induces an inflammatory response in the mouse lung. A role for interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Role of eosinophils in the pathogenesis of Mycobacterium bovis BCG infection in gamma interferon receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double-knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Defective NK cell activity and Th1 response in IL-18-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Differential potentiation of anti-mycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Nitric oxide production by peritoneal macrophages of Mycobacterium bovis BCG-infected or non-infected mice: regulatory role of T lymphocytes and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Lethal Mycobacterium bovis Bacillus Calmette Guérin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021

Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900196-8

7 January 2021